Technology

Cellular Biomedicine Group

$18.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-0.82%) As of 2:57 PM UTC today

Why Robinhood?

You can buy or sell CBMG and other stocks, options, and ETFs commission-free!

About CBMG

Cellular Biomedicine Group, Inc. Common Stock, also called Cellular Biomedicine Group, is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in New York, NY. The listed name for CBMG is Cellular Biomedicine Group, Inc. Common Stock.

CEO
Bi Zuo Liu
Employees
217
Headquarters
Gaithersburg, Maryland
Founded
2009
Market Cap
354.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
28.03K
High Today
$18.16
Low Today
$18.09
Open Price
$18.13
Volume
1.19K
52 Week High
$19.50
52 Week Low
$11.48

Collections

CBMG Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

HYMCW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure